UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1088) 1088
Book Chapter (33) 33
Magazine Article (6) 6
Newspaper Article (3) 3
Book / eBook (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (870) 870
life sciences & biomedicine (856) 856
humans (816) 816
biosimilar pharmaceuticals - therapeutic use (423) 423
biosimilar (342) 342
biosimilar pharmaceuticals - adverse effects (342) 342
biological products (295) 295
pharmacology & pharmacy (289) 289
biosimilars (276) 276
female (256) 256
male (248) 248
adult (225) 225
oncology (222) 222
middle aged (206) 206
treatment outcome (186) 186
biosimilar pharmaceuticals (184) 184
biosimilar pharmaceuticals - administration & dosage (181) 181
rheumatology (135) 135
therapeutic equivalency (134) 134
infliximab (133) 133
drug approval (131) 131
patients (129) 129
monoclonal antibodies (125) 125
rheumatoid arthritis (125) 125
immunogenicity (123) 123
medicine & public health (121) 121
safety (121) 121
animals (118) 118
biosimilar pharmaceuticals - pharmacokinetics (118) 118
clinical trials (117) 117
aged (116) 116
united states (115) 115
fda approval (110) 110
antibodies, monoclonal - therapeutic use (108) 108
medicine, research & experimental (103) 103
research & experimental medicine (103) 103
pharmaceutical industry (94) 94
pharmacology (94) 94
biosimilar pharmaceuticals - economics (93) 93
analysis (92) 92
immunology (92) 92
young adult (92) 92
antirheumatic agents - therapeutic use (88) 88
studies (86) 86
arthritis, rheumatoid - drug therapy (85) 85
pharmacokinetics (84) 84
double-blind method (83) 83
europe (83) 83
review (81) 81
antibodies (80) 80
biosimilar pharmaceuticals - pharmacology (80) 80
pharmacovigilance (79) 79
arthritis (76) 76
biotechnology & applied microbiology (76) 76
care and treatment (76) 76
infliximab - therapeutic use (76) 76
drugs (73) 73
inflammatory bowel disease (71) 71
hematology (68) 68
medicine (68) 68
research (68) 68
generic drugs (67) 67
drug therapy (66) 66
cancer (65) 65
proteins (65) 65
biomedicine (64) 64
internal medicine (64) 64
drug dosages (63) 63
neoplasms - drug therapy (63) 63
antirheumatic agents - adverse effects (62) 62
chemotherapy (62) 62
biologics (60) 60
biotechnology (60) 60
usage (60) 60
cancer research (59) 59
general & internal medicine (57) 57
medicine, general & internal (57) 57
adolescent (56) 56
biosimilar pharmaceuticals - standards (56) 56
drug substitution (56) 56
european union (56) 56
manufacturing (56) 56
pharmacology/toxicology (56) 56
pharmacotherapy (56) 56
psoriasis (56) 56
original (55) 55
cost control (54) 54
inflammatory bowel diseases - drug therapy (54) 54
interchangeability (54) 54
regulatory approval (54) 54
antibodies, monoclonal - adverse effects (53) 53
biological products - therapeutic use (53) 53
etanercept (52) 52
united states food and drug administration (52) 52
filgrastim (51) 51
gastroenterology & hepatology (51) 51
tumor necrosis factor-alpha - antagonists & inhibitors (51) 51
drug approval - legislation & jurisprudence (49) 49
neutropenia (49) 49
clinical trials as topic (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1112) 1112
German (13) 13
Spanish (9) 9
French (8) 8
Portuguese (4) 4
Russian (3) 3
Italian (2) 2
Dutch (1) 1
Icelandic (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2017, Volume 317, Issue 1, pp. 37 - 47
Journal Article
Journal Article
Journal Article
Digestive diseases and sciences, ISSN 0163-2116, 2017, Volume 62, Issue 11, pp. 3117 - 3122
Journal Article
Clinical and Experimental Rheumatology, ISSN 0392-856X, 2016, Volume 34, Issue 4, pp. 698 - 705
Inflammatory bowel disease | Anti-rheumatic agents | Rheumatoid arthritis | Biosimilar pharmaceuticals | CT-P13 | Therapeutic equivalence | Ankylosing spondylitis | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Rheumatic Diseases - drug therapy | Humans | Inflammatory Bowel Diseases - immunology | Antibodies, Monoclonal - adverse effects | Inflammatory Bowel Diseases - diagnosis | Antibodies, Monoclonal - therapeutic use | Drugs, Generic - therapeutic use | Anti-Inflammatory Agents - adverse effects | Patient Safety | Anti-Inflammatory Agents - therapeutic use | Antirheumatic Agents - adverse effects | Biosimilar Pharmaceuticals - pharmacokinetics | Anti-Inflammatory Agents - pharmacokinetics | Drug Evaluation, Preclinical | Gastrointestinal Agents - pharmacokinetics | Gastrointestinal Agents - standards | Drugs, Generic - standards | Antirheumatic Agents - therapeutic use | Quality Control | Rheumatic Diseases - immunology | Inflammatory Bowel Diseases - drug therapy | Biosimilar Pharmaceuticals - therapeutic use | Risk Assessment | Antirheumatic Agents - standards | Biosimilar Pharmaceuticals - standards | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Rheumatic Diseases - diagnosis | Patents as Topic | Anti-Inflammatory Agents - standards | Biosimilar Pharmaceuticals - adverse effects | Drugs, Generic - adverse effects | Animals | Drug Approval - methods | Gastrointestinal Agents - therapeutic use | Antirheumatic Agents - pharmacokinetics | Gastrointestinal Agents - adverse effects | Therapeutic Equivalency
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 01/2017, Volume 76, Issue 1, pp. 58 - 64
Journal Article